Heritage Cannabis Provides Update on Growth of Canadian Recreational Division and Launch of CB4 Branded Medical Products in Canada


Ryan Allway

July 29th, 2021

News


  • Sales of vape products in Q3 increased 119% quarter-over-quarter in the B.C. market.
  • In Ontario, Heritage achieved fastest growing concentrate sales and grew to #5 and #6 in sales in the concentrate category within one month of launching in the province.

TORONTO–(BUSINESS WIRE)–Heritage Cannabis Holdings Corp. (CSE: CANN) (OTCQX: HERTF) (“Heritage” or the “Company”), is pleased to provide an update on its growth in distribution of recreational products across Canada.

 

Heritage has continued its strong execution in the third quarter. Our second quarter results were a strong validation of our strategy as we posted a 250% quarter-over-quarter increase in revenue compared to the first quarter of 2021. We have continued to execute on our strategy and as a result have seen strong growth in shelf space for Heritage brands combined with increased product distribution across Canada. This is a noteworthy accomplishment as many companies are seeing a contraction in shelf space across the country given the crowded landscape.

 

Recreational Sales: Retail

Ontario

In Canada’s largest and most crowded market, Heritage continues to see growing interest in its premium and affordably priced products in the province of Ontario with 7 new SKUs added to the OCS in Q3. RAD Shatter products were the fastest growing products in the concentrates category and achieved #5 and #6 concentrate overall within one month of launching in the province. Additionally, in the oils category Heritage saw 40% growth in month-over-month sales, and vape sales grew 164% month-over-month.

 

Western Canada

In British Columbia, sales and recurring orders of products across all Heritage brands continue to accelerate, with a recent 119% quarter-over-quarter growth in vape sales. Currently RAD product is in 90% of the dispensaries in BC.

 

The RAD Sour Tangie High CBD and 1g Purefarma vapes recently launched in the province and are performing well to date. Heritage has shipped its first orders of RAD Reefer (flower) and RAD Doobie (pre-rolls) to the province and expects to introduce both products to additional provinces in Q4.

 

In Alberta, the province has listed 21 new Heritage SKUs, and RAD vapes have proven to be very popular as Heritage has seen consistent re-orders of RAD vapes from the province.

 

In Saskatchewan, Heritage added 35 new SKUs. The product launch was very successful with Saskatchewan re-ordering within weeks due to the positive sell through rate of Heritage brands. Both the Saskatchewan and Manitoba markets are a focus for Heritage, and we continue to see positive trends in re-order rates and market share wins.

 

Quebec

Heritage recently signed a supply agreement with Quebec based Medicibis to supply their medical platform Mendocannabis.ca with 61 SKUs, which are expected to be a considerable part of the medical cannabis offerings on the platform. Additionally, Heritage recently participated in a product call with The Société québécoise du cannabis (“SQDC”) and expect to have an initial 2-3 SKUs in the province following the completion of the product call in Q4.

 

Eastern Canada

In New Brunswick, Heritage has become the largest provider of concentrate products, and the Company recently saw 175% growth in sales in the province over the month of June 2021. In Newfoundland Heritage secured shelf space and shipped 27 new SKUs to the province and had re-orders from retailers a week later due to strong sell through. This is an exceptional result given Newfoundland’s process is on an annual basis.

 

Popularity is growing in Nova Scotia. Heritage brands now have 17.8% of the market share in the concentrates category, and RAD alone grew from 7.5% to 11.7% market share in a three month time-frame over the quarter.

 

Heritage has a strong market share in eastern Canadian provinces and is actively working to expand its brand offerings in the region, as well as add products in PEI.

 

Recreational Sales: Medical Channels

Both provincial and on-line platform sales continue to grow across Canada and Heritage is supplying 39 and 46 new SKUs to on-line platforms Shelter Market and Cannmart respectively.

 

“The market penetration of Heritage brands and products is accelerating across Canada with the acceptance of new SKUs and multiple re-orders. While we anticipate sales exceeding our historic Q2 results we are also focused on ensuring we can build a platform that can drive continued growth for our shareholders,” stated David Schwede, President of Heritage’s recreational cannabis division. “Our core focus is to create high-quality, appropriately priced products that align with what cannabis consumers want. Our recent performance has reinforced that consumers agree as the strength of the rate of re-orders, and period-over-period growth in sales in the provinces has continued. Our model is set to expand in the U.S. and we expect to accelerate our state by state expansion by leveraging our partnership with Merida Capital Holdings to advance the Company’s U.S. product distribution strategy and have products on U.S. shelves by the end of the year.”

 

Medical Division: First Product Launches in Canada

The Medical Division is launching its first six Opitcann medical “CB4” line of branded products to be sold through medical channel partners and through Heritage Patient Care starting in August 2021. CB4 products are backed by scientific performance data and include CB4 Relief and CB4 Relief-T oral CBD Softgel capsules formulated with VESIsorb® technology, as well as topical CB4 Relief Deep Rub Gel formulated with enhanced skin permeation technology for maximum absorption through the skin.

 

The Opticann suite of branded products also includes CB4 Control sublingual (under the tongue) filmstrips containing both CBD and CBDA based on Versafilm® pharmaceutical technology and are proven to deliver rapid and better absorption of ingredients from the sublingual cavity in a convenient dosage form. Additionally, Heritage will be launching CB4 Derma and CB4 Clear topical skincare products uniquely backed by product specific clinical trial data.

 

“We are excited to introduce the revolutionary CB4 suite of medical products that have been in development for a number of years,” stated Umar Syed, President of Heritage’s medical division. “Opticann’s CB4 products are formulated using proven pharmaceutical technology and are uniquely backed by objective scientific data that speaks to their efficacy for both health care practitioners and patients, addressing large unmet needs in the Canadian medical market. These products are well suited for mass medical adoption given their convenient dosing forms (gelcaps, filmstrips, and topical products) with which the medical and pharmacy communities are both familiar and comfortable prescribing and recommending as medical treatments.”

 

About Heritage Cannabis Holdings Corp.

Heritage is a leading cannabis company offering innovative products to both the medical and recreational legal cannabis markets in Canada and the U.S., operating under two licensed manufacturing facilities in Canada. The company has an extensive portfolio of high-quality cannabis products under the brands Purefarma, Pura Vida, RAD, Premium 5, feelgood., CB4 and ArthroCBD.

 

ON BEHALF OF THE BOARD OF DIRECTORS OF HERITAGE CANNABIS HOLDINGS CORP.

“Clint Sharples”

Clint Sharples
CEO

 

The Canadian Securities Exchange does not accept responsibility for the adequacy or accuracy of this release.

Contacts

Kelly Castledine
Tel: 647-660-2560
[email protected]

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.


Network Partners

Follow Us on Social Media

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading